The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma
Chemotherapy remains an inadequate treatment option for soft tissue sarcoma, and novel therapies are needed. The neoadjuvant space provides an excellent opportunity to study the effects of innovative treatments in soft tissue sarcoma.
Authors
- John Rieth (ORCID: https://orcid.org/0000-0002-4883-5301)
- Varun Monga (ORCID: https://orcid.org/0000-0002-1185-5448)
- Mohammed Milhem (ORCID: https://orcid.org/0000-0003-4663-6824)
Institutions
- University of Iowa Health Care (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3390/cancers17071203
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52